The global Endometrial Ablation Market size is expected to reach USD 5.4 billion by 2028, registering a CAGR of 5.2% over the forecast period, according to a new report by Grand View Research, Inc. Some of the key players in this industry are Medtronic, CooperSurgical Inc., Boston Scientific Corp., Ethicon, Inc. (Johnson & Johnson), Olympus Corp., Richard Wolf GmbH. Endometrial ablation is a highly efficient procedure that helps in removing or destroying the uterine endometrial lining in women who experience heavy menstrual bleeding using specific devices. The growing prevalence of gynecological disorders and growing public awareness about endometrial ablation are key contributing factors expected to propel the product demand. According to the International Federation of Gynecology and Obstetrics (FIGO), globally, the prevalence of Abnormal Uterine Bleeding (AUB) among reproductive-aged women is estimated to be between 3 to 30%
For women suffering from painful, heavy periods, endometrial ablation for endometriosis offers an alternative to chronic medication and hysterectomy treatments. Improved features and a higher demand for these procedures and devices due to the advantages over surgical methods, such as minimally invasive nature, low-risk profile, and easy operation, will support market growth. Many global, as well as local key players, are opting for different strategies. For instance, In March 2020, Mara Water Vapor Ablation System from AEGEA Medical has been approved by the U.S. FDA. Mara is the endometrial ablation procedure that uses natural water vapor to safely cure heavy menstrual bleeding without the need for general anesthesia. Endometrial ablation procedures have proven effective in about 10% of people to no longer have menstrual periods. Bleeding is effectively decreased in another 70% of cases. However, there are certain side effects associated with the procedure, which include infection, tearing of the uterine wall or bowel, which may hamper the market growth. As a result of the COVID-19 pandemic, the healthcare system had to deal with a lot of difficulties, all outpatient procedures were limited or stopped to lower the impact of virus outbreaks. This also had a negative impact on the overall market growth. Related Press Release@ Endometrial Ablation Market Report Endometrial Ablation Market Report Highlights
0 Comments
The Chile Ultrasound Devices Market size is expected to reach USD 192.3 million by 2028. The market is expected to expand at a CAGR of 2.3% from 2021 to 2028. The increasing prevalence of lifestyle-associated diseases and technological advancements are some of the major market players. Cancer affects a considerable portion of the Chilean population, with prostate cancer ranking 1 amongst others, the adoption of ultrasound devices in the diagnosis of cancer is expected to boost the market growth. Additionally, manufacturers are using new strategies that allow them to use their resources to help develop new products and improve their supply chain. For instance, In March 2021, GE Healthcare announced the launch of Vscan Air, new wireless, hand-held ultrasound device, it is about the size of an iPhone and connects to a smartphone app to read the ultrasound images.
The Chilean government is committed to investment in health infrastructure, and in 2018 President unveiled Chile's 2018-2022 USD 10 billion hospital infrastructure plan. However, the health system in Chile is strained due to a lack of skilled medical staff. According to the ministry of foreign affairs, in 2016, there were 2.3 doctors per 1000 persons. For medical devices and supplies, Chile is 95% reliant on imports. The medical device market in Chile is competitive, with numerous companies from around the world easily finding their way in. The rise in public hospital infrastructure will create an increased demand for ultrasound devices as the Chilean government will invest large sums in hospital construction in the future years. Related Press Release@ Chile Ultrasound Devices Market Report Chile Ultrasound Devices Market Report Highlights
The global Dental Suction Systems Market size is expected to reach USD 639.2 million by 2028, registering a CAGR of 10.2% over the forecast period, according to a new report by Grand View Research, Inc. The growth is attributable to technological advancements in dental suction products. Moreover, an increasing number of dental surgical procedures is expected to contribute to the growth of the market. Technological advancements are also expected to favor market growth. For instance, Tyscor, a new suction unit, is energy-efficient and saves more than 50% of energy. The device is also lightweight & compact and it can convert the dry suction unit to a wet suction unit. In addition, the device is the first spray mist suction unit with radial technology in the dental market.
The patients and dental staff are at high risk to get infected by the spread of harmful aerosols that are generated during dental procedures. Many people during the COVID-19 pandemic actively avoided visiting hospitals and dental clinics frequently to protect themselves from getting infected by the coronavirus. According to the Agency for Healthcare Research and Quality, in August 2020, the outbreak of coronavirus disease in 2019 had led to the closure of approximately 198,000 active dental specialists and dentists’ offices in the U.S. This has reduced the number of dental procedures and affected the overall market. Related Press Release@ Dental Suction Systems Market Report Dental Suction Systems Market Report Highlights
Thailand Aesthetic Medicine Market Size is Expected to Experience a CAGR of 13.6% till 20282/21/2022 ![]() The Thailand Aesthetic Medicine Market size is expected to reach USD 1.89 billion by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 13.6% from 2021 to 2028. The market is majorly driven by the increasing adoption of minimally invasive and non-invasive procedures, coupled with the growth in the population susceptible to signs of aging. Moreover, an increase in the incidence of road accidents is driving the demand for reconstructive surgeries, which is fuelling the growth of the aesthetic medicine market in the country. According to the International Society of Aesthetic Plastic Surgery (ISAPS), among Asian countries, Thailand is among the top ten countries with the highest number of invasive as well as non-invasive procedures. Cities such as Bangkok and Phuket are major cosmetic surgery hubs in the country, which have clusters of major aesthetic surgery hospitals and clinics. According to a survey by the International Society of Aesthetic Plastic Surgery in 2019, around 92,597 invasive aesthetic procedures were performed in the country. Moreover, Thailand is a tourism-dependent economy where medical tourism is flourishing due to low treatment costs and high-quality post-treatment services. According to the Journal of Community Development Research, Thailand’s medical tourism industry expanded with a 10% revenue growth in 2019 from 2018. These factors might boost the growth of the aesthetic medicine market. The advent of the Covid-19 pandemic has resulted in the cessation of medical tourism in Thailand. The majority of the medical tourists visit the country for cosmetic procedures, however, the international travel ban and lockdown restrictions due to the pandemic have resulted in the shutting down of aesthetic clinics, thereby affecting the country’s aesthetic medicine market. However, according to Bangkok Post, Thailand Centre for Covid-19 Situation Administration stated that they have resumed the country’s medical and wellness tourism program intending to attract medical tourists back into the country. The aesthetic market revenue is expected to plunge back to pre-Covid levels by the end of 2022. Related Press Release@ Thailand Aesthetic Medicine Market Report Thailand Aesthetic Medicine Market Report Highlights
The global Clinical Trial Equipment & Ancillary Solutions Market size is anticipated to reach USD 4.4 billion by 2028, according to the new report of Grand View Research, Inc., expanding at a CAGR of 8.2% over the forecast period. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market.
The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites. As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations. The COVID-19 pandemic has affected the global market, which resulted in slowing down the supply chain of the equipment & ancillary supplies. The COVID-19 pandemic has caused major changes in the clinical trial environment. Hundreds of experiments that were in progress before the pandemic have been halted, while many new trials have been launched in the hunt for effective therapies and interventions. COVID-19 has changed the way clinical trials are conducted, encouraging the digitization of healthcare and the adoption of cutting-edge technologies and techniques. Related Press Release@ Clinical Trial Equipment & Ancillary Solutions Market Report Clinical Trial Equipment & Ancillary Solutions Market Report Highlights
The Australia Legal Cannabis Market size is expected to reach USD 375.7 million by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 32.7% from 2021 to 2028. The increasing legalization of cannabis, rising patient population, increasing government support, and the availability of local and international players in the country are some of the major factors boosting the country’s growth. In addition, the surge in medical marijuana production owing to its increasing demand in the pharmaceutical sector is further propelling overall growth. The COVD-19 pandemic has negatively impacted the country’s growth rate due to supply chain restrictions imposed due to nationwide lockdown.
As of 2020, the hemp product type segment held the largest revenue share. The market growth is attributed to the rising adoption of hemp-based products for various medical and industrial purposes. The increasing prevalence of epilepsy and other sleep disorders is aiding the product adoption thereby, positively contributing to the segment growth. On the other hand, the marijuana segment is anticipated to be the fastest-growing segment during the forecast period owing to the increasing legalization of these products for medical and adult use and increasing consumer shift towards purchasing the product through legal channels. The industrial application segment accounted for the majority share in 2020. Growing demand for hemp fibers and oil in the construction, food and beverage, personal care, automotive, and textile industries is aiding segment growth. On the other hand, the medical application segment is expected to be the fastest-growing segment during the forecast period owing to awareness regarding health benefits offered by cannabis products for various medical applications, including anxiety, chronic pain, sleep disorder, and inflammation. Related Press Release@ Australia Legal Cannabis Market Report Australia Legal Cannabis Market Report Highlights
The global Neurovascular Catheters Market size is anticipated to reach USD 4.83 billion by 2028, expanding at a CAGR of 6.7% over the forecast period, according to a new report by Grand View Research, Inc. Increasing demand for minimally invasive neurosurgical procedures, rising prevalence of stroke and brain aneurysm, and technological advancements are driving the market.
Stroke is the most common cause of death, followed by heart and cancer diseases worldwide. For instance, according to WHO, in 2016, 15.2 million deaths of the 56.9 million deaths worldwide were due to stroke. Acute Ischemic Stroke (AIS) is the most common form of stroke caused due to reduced blood supply to the brain, making brain cells die. For instance, according to the U.S. CDC, 87.0% of strokes are classified as ischemic strokes, with the U.S. being the most commonly affected country. Various initiatives are undertaken by the government worldwide to prevention stroke. For instance, the Well-Integrated Screening and Evaluation for Women Across the Nation (WISEWOMAN) program was started by the U.S. CDC in three states: North Carolina, Massachusetts, and Arizona, to minimize the risk of stroke and other neurovascular diseases in women by promoting a healthy lifestyle. Related Press Release@ Neurovascular Catheters Market Report Neurovascular Catheters Market Report Highlights
The global Per Diem Nurse Staffing Market size is expected to reach USD 11.1 billion by 2028, registering a CAGR of 4.9% over the forecast period, according to a new report by Grand View Research, Inc. Higher demand for medical-surgical nurses & increased utilization of staffing agencies, and the rising demand for family nurse practitioners are driving the market. The rising geriatric population leads to an increase in the number of hospital admissions, which is another key factor boosting the market growth.
Moreover, the spread of infectious diseases, especially during flu season, is an important factor resulting in a sudden increase in the number of hospital admissions, thereby creating the need for additional nursing staff. For example, according to the Centers for Disease Control and Prevention (CDC), an estimated 959,000 people were hospitalized because of the 2017-2018 influenza season in the U.S. Similarly, the 2018-2019 flu season accounted for 69,000-84,000 hospital admissions in the U.S. Such temporary need for an additional nurse workforce can be easily fulfilled by per diem nurses, thereby augmenting the market growth. The COVID-19 pandemic has increased the pressure on the medical workforce. With hospitals being overburdened with COVID-19 patients, the demand for per diem nurse staffing is increasing exponentially. At this point, the main aim of healthcare facilities is to deploy the maximum number of medical staff for the management of COVID-19 patients. Thus, the pandemic is driving market growth. With more patients being hospitalized, more nurses are required for the care, which is impelling the need for temporary nurses. According to June Pulse Survey by Staffing Industry Analysts (SIA), the demand for pre diem staffing increased by 6% during the COVID-19 pandemic. However, lower job security and stringent regulations are creating negativity in nurses to work as per diem nurses, which is a big challenge to the market. Related Press Release@ Per Diem Nurse Staffing Market Report Per Diem Nurse Staffing Market Report Highlights
Surgical Drainage Devices Market by Acelity, Teleflex Incorporated, Cardinal Health, Medtronic2/18/2022 The global Surgical Drainage Devices Market size is anticipated to reach USD 2.57 billion by 2028, expanding at a CAGR of 5.6% over the forecast period, according to a new report by Grand View Research, Inc. The growth of this market is catapulted by the increasing incidence of chronic diseases, the need to curb healthcare expenditure, and the additional benefits associated with surgical drain devices. The majority of the time, these devices are used for the prevention of fluid accumulation and in post-surgical treatment & care.
With the escalating number of diseases that require surgical intervention, these devices are now being used in hospitals, clinics, and ambulatory surgical centers. Active surgical drain devices make use of negative pressure or vacuum to remove fluid buildup and are preferred over conventional passive drain devices as they help in healing the wound quickly. Drainage devices are used in cardiothoracic surgeries, neurosurgical procedures, orthopedic surgeries, and abdominal surgeries among others. The global rise in musculoskeletal diseases, arthritis, and osteoporosis has resulted in an increase in the number of surgeries being performed, which has further led to an increase in the adoption of these devices. The North American region accounted for the largest market share due to technologically advanced medical infrastructure and the successful integration of ambulatory health services in its healthcare system. Emerging countries like India, China, and Brazil are also expected to flourish during the forecast period owing to their developing healthcare infrastructure and increasing adoption of advanced medical technology to curb chronic diseases. Related Press Release@ Surgical Drainage Devices Market Report Surgical Drainage Devices Market Report Highlights
The global Viscosupplementation Market size is expected to reach USD 7.6 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to grow at a CAGR of 9.37% from 2021 to 2028. Initiatives to increase awareness regarding available treatment, the rising geriatric population, and product advancements are expected to boost market growth during the forecast period. With the growing geriatric population, the burden of osteoarthritis is expected to increase dramatically. As per the Arthritis Foundation, in the U.S., around 54.4 million adults are reported to be diagnosed with doctor-diagnosed arthritis.
Favorable reimbursement policies with respect to the geriatric population are expected to act as an opportunity for market growth. The viscosupplementation business was affected due to the COVID-19 pandemic as many healthcare providers postponed the nonessential patient visits, such as osteoarthritis treatments. Although ease in COVID-19 restrictions regarding surgeries led to a recovery in surgery volume, certain markets, such as Spain, the U.K., and Italy witnessed a low pace of recovery. Asia Pacific held the largest revenue share of the global market in 2020. In recent years, exponential growth in the number of orthopedic surgeons in developing countries, such as South Korea, Russia, and China, was observed. Asia Pacific region presents high growth potential owing to large patient population and untapped opportunities in comparison with the U.S. Therefore, the introduction of products by the players in Asian countries is further expected to propel the market growth. In July 2017, Anika Therapeutics announced regulatory approval of MONOVISC in India followed by approval in Australia in October 2017. However, such strategic initiatives were offset to some extent by the impact of the COVID-19 pandemic, which led to the disruption of company operations. Europe is expected to register the fastest CAGR during the forecast period. This can be attributed to a large number of clinical trials being conducted in the region to provide efficient treatment for knee osteoarthritis with the help of stem cells. Related Press Release@ Viscosupplementation Market Report Viscosupplementation Market Report Highlights
|
Archives
October 2023
|